Product
TAF/EVG
2 clinical trials
2 indications
Indication
Safety IssuesIndication
HIV InfectionsClinical trial
A Phase I Randomized, Placebo-controlled, Double-blind Study to Assess Safety, Pharmacokinetics, and Modeled Pharmacodynamics of a Vaginal Insert Containing Tenofovir Alafenamide and ElvitegravirStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Phase 1 Open Label Safety and Pharmacokinetic Study of Rectal Administration of a Tenofovir Alafenamide/Elvitegravir Insert at Two Dose LevelsStatus: Completed, Estimated PCD: 2021-03-03